{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:35:17Z","timestamp":1768592117565,"version":"3.49.0"},"reference-count":22,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1210\/jc.2017-00199","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T23:22:40Z","timestamp":1491434560000},"page":"2335-2339","source":"Crossref","is-referenced-by-count":7,"title":["Tolerance Does Not Develop Toward Liraglutide\u2019s Glucose-Lowering Effect"],"prefix":"10.1210","volume":"102","author":[{"given":"Tuuli","family":"Sedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eero","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallo","family":"Volke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20170706140117_B1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"American Diabetes Association (ADA)","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170706140117_B2","first-page":"S1","article-title":"Canadian Diabetes Association clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2013","journal-title":"Can J Diabetes"},{"issue":"7","key":"key\n\t\t\t\t20170706140117_B3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/dom.12465","article-title":"Incretin-based medications for type 2 diabetes: an overview of reviews","volume":"17","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"key\n\t\t\t\t20170706140117_B4","first-page":"407","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study","volume":"102","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20170706140117_B5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2337\/dc15-1274","article-title":"Effect of the GLP-1 receptor agonist lixisenatide on counterregulatory responses to hypoglycemia in subjects with insulin-treated type 2 diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"10","key":"key\n\t\t\t\t20170706140117_B6","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","year":"2014","journal-title":"J Clin Invest"},{"issue":"12","key":"key\n\t\t\t\t20170706140117_B7","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"key\n\t\t\t\t20170706140117_B8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2015-3291","article-title":"Decreased hypothalamic glucagon-like peptide-1 receptor expression in type 2 diabetes patients","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20170706140117_B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2042018814558242","article-title":"Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus","volume":"6","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20170706140117_B10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","year":"2006","journal-title":"Cell Metab"},{"issue":"6","key":"key\n\t\t\t\t20170706140117_B11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1463-1326.2012.01557.x","article-title":"Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight","volume":"14","year":"2012","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"key\n\t\t\t\t20170706140117_B12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1601-5215.2012.00648.x","article-title":"Acute administration of GLP-1 receptor agonists induces hypolocomotion but not anxiety in mice","volume":"24","year":"2012","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"key\n\t\t\t\t20170706140117_B13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/neu.2014.36","article-title":"GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment","volume":"27","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"key\n\t\t\t\t20170706140117_B14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cmet.2016.01.009","article-title":"Liraglutide compromises pancreatic \u03b2 cell function in a humanized mouse model","volume":"23","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"key\n\t\t\t\t20170706140117_B15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0169-2607(96)01755-5","article-title":"ISEC: a program to calculate insulin secretion","volume":"50","year":"1996","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"key\n\t\t\t\t20170706140117_B16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dmr.5610100204","article-title":"How to measure insulin secretion","volume":"10","year":"1994","journal-title":"Diabetes Metab Rev"},{"issue":"23","key":"key\n\t\t\t\t20170706140117_B17","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"ELIXA Investigators","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170706140117_B18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"LEADER Steering Committee","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170706140117_B19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/db13-0893","article-title":"Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia","volume":"63","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"key\n\t\t\t\t20170706140117_B20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"key\n\t\t\t\t20170706140117_B21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00125-001-0719-z","article-title":"The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men","volume":"45","year":"2002","journal-title":"Diabetologia"},{"issue":"9","key":"key\n\t\t\t\t20170706140117_B22","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc14-0398","article-title":"Effect of exenatide, sitagliptin, or glimepiride on \u03b2-cell secretory capacity in early type 2 diabetes","volume":"37","year":"2014","journal-title":"Diabetes Care"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/7\/2335\/18171522\/jc.2017-00199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T07:19:47Z","timestamp":1658906387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jc.2017-00199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,3,31]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-00199","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}